▶ 調査レポート

成人異常ヘモグロビン症検査の世界市場

• 英文タイトル:Global Market Study on Adult Hemoglobinopathy Testing: HPLC Test Type to Lead in Terms of Market Share Through 2026

Persistence Market Researchが調査・発行した産業分析レポートです。成人異常ヘモグロビン症検査の世界市場 / Global Market Study on Adult Hemoglobinopathy Testing: HPLC Test Type to Lead in Terms of Market Share Through 2026 / B10PMR03資料のイメージです。• レポートコード:B10PMR03
• 出版社/出版日:Persistence Market Research / 2018年8月14日
• レポート形態:英文、PDF、217ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:ライフサイエンス・転換期医療
• 販売価格(消費税別)
  Individual(1名、印刷不可)¥509,600 (USD4,900)▷ お問い合わせ
  Multi User(5名)¥790,400 (USD7,600)▷ お問い合わせ
  Corporate User¥1,102,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、成人異常ヘモグロビン症検査の世界市場について調べ、成人異常ヘモグロビン症検査の世界規模、市場動向、市場環境、変異型別(ヘモグロビンF、ヘモグロビンA2)分析、検査タイプ別(HPLC法、Hb電気泳動、質量分析)分析、エンドユーザー別(リファレンスラボラトリー、病院、学術機関・医療機関)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・エグゼクティブサマリー
・調査手法
・成人異常ヘモグロビン症検査の世界市場環境
・成人異常ヘモグロビン症検査の世界市場動向
・成人異常ヘモグロビン症検査の世界市場規模
・成人異常ヘモグロビン症検査の世界市場規模:変異型別(ヘモグロビンF、ヘモグロビンA2)
・成人異常ヘモグロビン症検査の世界市場規模:検査タイプ別(HPLC法、Hb電気泳動、質量分析)
・成人異常ヘモグロビン症検査の世界市場規模:エンドユーザー別(リファレンスラボラトリー、病院、学術機関・医療機関)
・成人異常ヘモグロビン症検査の世界市場:地域別市場規模・分析
・成人異常ヘモグロビン症検査の北米市場規模・予測
・成人異常ヘモグロビン症検査のアメリカ市場規模・予測
・成人異常ヘモグロビン症検査のヨーロッパ市場規模・予測
・成人異常ヘモグロビン症検査のアジア市場規模・予測
・成人異常ヘモグロビン症検査の日本市場規模・予測
・成人異常ヘモグロビン症検査の中国市場規模・予測
・成人異常ヘモグロビン症検査のインド市場規模・予測
・関連企業情報・競争状況

This Persistence Market Research (PMR) report examines the ‘Global Adult Hemoglobinopathy Testing Market’ for the period 2018–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global adult hemoglobinopathy testing market.

The Adult Hemoglobinopathy Testing Market is Segmented Based on:

Variant Type
Test Type
End Users
Region
This report covers the global adult hemoglobinopathy testing market performance in terms of revenue contribution from various segments. The global adult hemoglobinopathy testing market report begins with an overview and definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the global adult hemoglobinopathy testing market along with detailed opportunity analysis of the market. This is then followed by the key drivers, restraints and trends of the global adult hemoglobinopathy testing market.

The global adult hemoglobinopathy testing market is segmented based on variant type, test type, end users and regions. Based on variant type, the global adult hemoglobinopathy testing market is segmented into variant A2 and variant F. Based on test type, the global adult hemoglobinopathy testing market is segmented into HPLC Test, mass spectrometry and Hb electrophoresis. Based on end users, the global adult hemoglobinopathy testing market is segmented into hospitals, reference laboratories and academic & medical institutes. Geographically, the global adult hemoglobinopathy testing market is segmented into North America (the U.S. & Canada), Latin America (Brazil, Mexico, and Rest of Latin America), Europe (Germany, France, the U.K., Italy, Spain and Rest of Europe), Asia Pacific excluding Japan (China, India, Australia & New Zealand and Rest of Asia Pacific), Japan and Middle-East and Africa (GCC Countries, South Africa and Rest of MEA).

A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The forecast of the adult hemoglobinopathy testing market by country, variant type, test type and end users is represented in a tabular form for each region. This section will help to understand the present scenario and opportunities of the adult hemoglobinopathy testing market in major countries by each segment.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view of the key competitor firms in order to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segment. The detailed profiles of players operating in the adult hemoglobinopathy testing market are also provided in the report, which highlight company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the report highlights the market outlook for 2018–2026 and sets the forecast within the context of the adult hemoglobinopathy testing market by region. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index.

The above sections – by variant type, test type and end users – evaluate the historic market analysis and growth prospects of the adult hemoglobinopathy testing market for the period 2018–2026. We have considered 2017 as the base year and provided data for the forecast period.

The final section of the report represents the global scenario of the adult hemoglobinopathy testing market along with y-o-y growth and market forecast till 2026. This section also evaluates the global market opportunity over the forecast period as well as the absolute dollar opportunity for each year. This section will help to understand the overall growth of the adult hemoglobinopathy testing market and the opportunity analysis for every year over the forecast period.

To arrive at the market size, bottom-up approach is used to validate the total market size obtained for the adult hemoglobinopathy testing market. The forecast presented in the report provides total revenue of the adult hemoglobinopathy testing market over 2018–2026. PMR has used a triangulation methodology that is primarily based on experimental techniques, such as patient-level data to obtain precise market estimations for adult hemoglobinopathy testing market and insights on specific country/regions. The country-specific data is again analyzed to derive data at a regional level and then at the global level. This methodology ensures high quality and accuracy of information.

The factors considered while developing the estimates of the adult hemoglobinopathy testing market are disease epidemiology, treatment seeking rate, ratio of population prescribed with different level of testing from complete blood count test to genetic and molecular testing for hemoglobinopathy.

The average selling price (US$) is derived by using weighted average pricing methodology.

On the other hand, PMR has also analyzed the market by considering the revenue from the key players operating a segment. The key players are segmented at the tier level with respect to their revenue, product portfolio and geographical presence. This process involves analysis of various annual reports of companies, investor presentations, SEC filings, 10k reports, earning call transcripts and press releases. This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share.

Revenue growth of the key market players is analyzed over the historical period and qualitative assessment of new product launches and innovations has been made in order to validate and align the resultant market numbers. The market structure is closely studied and analyzed at the regional level to map and ascertain incremental $ opportunity for companies, for instance, supply from domestic/regional players, small-scale enterprises or unorganized segments is also taken into consideration to arrive at the final market numbers.

While forecasting the size of the adult hemoglobinopathy testing market, we have considered the impact of several factors such as per capital healthcare expenditure, disposable income, new testing methods and approvals for new rapid POC tests, penetration of adult hemoglobinopathy testing through various end users, generic penetration across all regions, etc. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

レポート目次

Table of Content

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Adult Hemoglobinopathy Testing Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Trends
4.2. Reimbursement Scenario
4.3. Regional Pricing Analysis by Test Type (2017)
4.4. Disease Epidemiology (2017)

5. North America Adult Hemoglobinopathy Testing Market Analysis 2013–2017 and Forecast 2018–2026
5.1. Introduction
5.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
5.2.1. U.S.
5.2.2. Canada
5.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
5.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2013–2017
5.4.1. Hemoglobin F
5.4.2. Hemoglobin A2
5.5. Market Size (US$ Mn) Forecast By Variant Type, 2018–2026
5.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2013–2017
5.6.1. HPLC Test
5.6.2. Hb Electrophoresis
5.6.3. Mass Spectrometry
5.7. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
5.8.1. Reference Laboratories
5.8.2. Hospitals
5.8.3. Academic and Medical Institutes
5.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
5.10.Market Attractiveness Analysis
5.10.1. By Country
5.10.2. By Variant Type
5.10.3. By Test Type
5.10.4. By End User
5.11.Drivers and Restraints – Impact Analysis

6. Latin America Adult Hemoglobinopathy Testing Market Analysis 2012–2016 and Forecast 2017–2025
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012–2016
6.2.1. Brazil
6.2.2. Mexico
6.2.3. Rest of Latin America
6.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
6.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2013–2017
6.4.1. Hemoglobin F
6.4.2. Hemoglobin A2
6.5. Market Size (US$ Mn) Forecast By Variant Type, 2018–2026
6.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2013–2017
6.6.1. HPLC Test
6.6.2. Hb Electrophoresis
6.6.3. Mass Spectrometry
6.7. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
6.8.1. Reference Laboratories
6.8.2. Hospitals
6.8.3. Academic and Medical Institutes
6.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
6.10.Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Variant Type
6.10.3. By Test Type
6.10.4. By End User
6.11.Drivers and Restraints – Impact Analysis

7. Europe Adult Hemoglobinopathy Testing Market Analysis 2012–2016 and Forecast 2017–2025
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.2.1. Germany
7.2.2. U.K.
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2013–2017
7.4.1. Hemoglobin F
7.4.2. Hemoglobin A2
7.5. Market Size (US$ Mn) Forecast By Variant Type, 2018–2026
7.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2013–2017
7.6.1. HPLC Test
7.6.2. Hb Electrophoresis
7.6.3. Mass Spectrometry
7.7. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
7.8.1. Reference Laboratories
7.8.2. Hospitals
7.8.3. Academic and Medical Institutes
7.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
7.10.Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Variant Type
7.10.3. By Test Type
7.10.4. By End User
7.11.Drivers and Restraints – Impact Analysis

8. Asia Pacific Excluding Japan Adult Hemoglobinopathy Testing Market Analysis 2012–2016 and Forecast 2017–2025
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.2.1. China
8.2.2. India
8.2.3. Australia and New Zealand
8.2.4. Rest of Asia Pacific
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2013–2017
8.4.1. Hemoglobin F
8.4.2. Hemoglobin A2
8.5. Market Size (US$ Mn) Forecast By Variant Type, 2018–2026
8.6. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2013–2017
8.6.1. HPLC Test
8.6.2. Hb Electrophoresis
8.6.3. Mass Spectrometry
8.7. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
8.8.1. Reference Laboratories
8.8.2. Hospitals
8.8.3. Academic and Medical Institutes
8.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
8.10.Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Variant Type
8.10.3. By Test Type
8.10.4. By End User
8.11.Drivers and Restraints – Impact Analysis

9. Japan Adult Hemoglobinopathy Testing Market Analysis 2012–2016 and Forecast 2017–2025
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2013–2017
9.2.1. Hemoglobin F
9.2.2. Hemoglobin A2
9.3. Market Size (US$ Mn) Forecast By Variant Type, 2018–2026
9.4. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2013–2017
9.4.1. HPLC Test
9.4.2. Hb Electrophoresis
9.4.3. Mass Spectrometry
9.5. Market Size (US$ Mn) Forecast By Test Type, 2018–2026
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
9.6.1. Reference Laboratories
9.6.2. Hospitals
9.6.3. Academic and Medical Institutes
9.7. Market Size (US$ Mn) Forecast By End User, 2018–2026
9.8. Market Attractiveness Analysis
9.8.1. By Variant Type
9.8.2. By Test Type
9.8.3. By End User
9.9. Drivers and Restraints – Impact Analysis

10. Middle East & Africa Adult Hemoglobinopathy Testing Market Analysis 2012–2016 and Forecast 2017–2025
10.1.Introduction
10.2.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of MEA
10.3.Market Size (US$ Mn) Forecast By Country, 2018–2026
10.4.Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2013–2017
10.4.1. Hemoglobin F
10.4.2. Hemoglobin A2
10.5.Market Size (US$ Mn) Forecast By Variant Type, 2018–2026
10.6.Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2013–2017
10.6.1. HPLC Test
10.6.2. Hb Electrophoresis
10.6.3. Mass Spectrometry
10.7.Market Size (US$ Mn) Forecast By Test Type, 2018–2026
10.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
10.8.1. Reference Laboratories
10.8.2. Hospitals
10.8.3. Academic and Medical Institutes
10.9.Market Size (US$ Mn) Forecast By End User, 2018–2026
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Variant Type
10.10.3. By Test Type
10.10.4. By End User
10.11. Drivers and Restraints – Impact Analysis

11. Forecast Assumptions

12. Competition Analysis
12.1. Competition Dashboard
12.2. Company Deep Dive
12.2.1. Bio-Rad Laboratories, Inc.
12.2.1.1. Overview
12.2.1.2. Product and Application Portfolio
12.2.1.3. Production Footprint
12.2.1.4. Sales Footprint
12.2.1.5. Channel Footprint
12.2.1.6. Strategy
12.2.1.6.1. Marketing Strategy
12.2.1.6.2. Product Strategy
12.2.1.6.3. Channel Strategy
12.2.2. Thermo Fisher Scientific Inc.
12.2.2.1. Overview
12.2.2.2. Product and Application Portfolio
12.2.2.3. Production Footprint
12.2.2.4. Sales Footprint
12.2.2.5. Channel Footprint
12.2.2.6. Strategy
12.2.2.6.1. Marketing Strategy
12.2.2.6.2. Product Strategy
12.2.2.6.3. Channel Strategy
12.2.3. PerkinElmer Inc.
12.2.3.1. Overview
12.2.3.2. Product and Application Portfolio
12.2.3.3. Production Footprint
12.2.3.4. Sales Footprint
12.2.3.5. Channel Footprint
12.2.3.6. Strategy
12.2.3.6.1. Marketing Strategy
12.2.3.6.2. Product Strategy
12.2.3.6.3. Channel Strategy
12.2.4. Chromsystems Instruments & Chemicals GmbH
12.2.4.1. Overview
12.2.4.2. Product and Application Portfolio
12.2.4.3. Production Footprint
12.2.4.4. Sales Footprint
12.2.4.5. Channel Footprint
12.2.4.6. Strategy
12.2.4.6.1. Marketing Strategy
12.2.4.6.2. Product Strategy
12.2.4.6.3. Channel Strategy
12.2.5. BioMedomics, Inc
12.2.5.1. Overview
12.2.5.2. Product and Application Portfolio
12.2.5.3. Production Footprint
12.2.5.4. Sales Footprint
12.2.5.5. Channel Footprint
12.2.5.6. Strategy
12.2.5.6.1. Marketing Strategy
12.2.5.6.2. Product Strategy
12.2.5.6.3. Channel Strategy
12.2.6. CapitalBio Technology Inc
12.2.6. Overview
12.2.6.2. Product and Application Portfolio
12.2.6.3. Production Footprint
12.2.6.4. Sales Footprint
12.2.6.5. Channel Footprint
12.2.6.6. Strategy
12.2.6.6.1. Marketing Strategy
12.2.6.6.2. Product Strategy
12.2.6.6.3. Channel Strategy
12.2.7. Trinity Biotech
12.2.7.1. Overview
12.2.7.2. Product and Application Portfolio
12.2.7.3. Production Footprint
12.2.7.4. Sales Footprint
12.2.7.5. Channel Footprint
12.2.7.6. Strategy
12.2.7.6.1. Marketing Strategy
12.2.7.6.2. Product Strategy
12.2.7.6.3. Channel Strategy
12.2.8. Streck, Inc .
12.2.8.1. Overview
12.2.8.2. Product and Application Portfolio
12.2.8.3. Production Footprint
12.2.8.4. Sales Footprint
12.2.8.5. Channel Footprint
12.2.8.6. Strategy
12.2.8.6.1. Marketing Strategy
12.2.8.6.2. Product Strategy
12.2.8.6.3. Channel Strategy

13. Global Adult Hemoglobinopathy Testing Market Analysis 2013–2017 and Forecast 2018–2026, By Region
13.1.Introduction/Key Findings
13.2.Historical Market Size (US$ Mn) Analysis By Region, 2013–2017
13.3.Market Size (US$ Mn) Forecast By Region, 2018–2026
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Asia Pacific
13.3.5. Middle East & Africa
13.4.Market Attractiveness Analysis By Region

14. Global Adult Hemoglobinopathy Testing Market Analysis 2013–2017 and Forecast 2018–2026, By Variant Type
14.1.Introduction/Key Findings
14.2.Historical Market Size (US$ Mn) Trend Analysis By Variant Type, 2013–2017
14.2.1. Hemoglobin F
14.2.2. Hemoglobin A2
14.3.Market Size (US$ Mn) Forecast By Variant Type, 2018–2026
14.4.Key Market Attractiveness Analysis

15. Global Adult Hemoglobinopathy Testing Market Analysis 2013–2017 and Forecast 2018–2026, By Test Type
Classification of Test Type; highlighting historical trends, current market value, and future projections on the basis of key segments
15.1.Introduction/Key Findings
15.2.Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2013–2017
15.2.1. HPLC Test
15.2.2. Hb Electrophoresis
15.2.3. Mass Spectrometry
15.3.Market Size (US$ Mn) Forecast By Test Type, 2018–2026
15.4. Market Attractiveness Analysis

16. Global Adult Hemoglobinopathy Testing Market Analysis 2013–2017 and Forecast 2018–2026, By End User
16.1.Introduction/Key Findings
16.2.Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
16.2.1. Reference Laboratories
16.2.2. Hospitals
16.2.3. Academic and Medical Institutes
16.3.Market Size (US$ Mn) Forecast By End User, 2018–2026
16.4.Market Attractiveness Analysis

17. Global Adult Hemoglobinopathy Testing Market Analysis 2013–2017 and Forecast 2018–2026
17.1.Market Value (US$ Mn) Projections
17.2.Y-o-Y Growth Analysis
17.3.Absolute $ Opportunity
17.4 Research Methodology

List of Tables

Table 01: North America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 02: North America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Variant Type
Table 03: North America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Test Type
Table 04: North America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 05: Latin America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 06: Latin America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Variant Type
Table 07: Latin America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Test Type
Table 08: Latin America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 09: Europe Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 10: Europe Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Variant Type
Table 11: Europe Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Test Type
Table 12: Europe Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 13: Asia Pacific Excluding Japan Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: Asia Pacific Excluding Japan Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Variant Type
Table 15: Asia Pacific Excluding Japan Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Test Type
Table 16: Asia Pacific Excluding Japan Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 17: Japan Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Variant Type
Table 18: Japan Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Test Type
Table 19: Japan Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 20: Middle East & Africa Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 21: Middle East & Africa Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Variant Type
Table 22: Middle East & Africa Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Test Type
Table 23: Middle East & Africa Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 24: Global Adult Hemoglobinopathy Testing Market Size (US$ Mn) 2011–2017 and Forecast 2018-2026 By Region,
Table 25: North America Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Variant Type
Table 26: Global Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Test Type
Table 27: Global Adult Hemoglobinopathy Testing Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User